Androgen inducibility of Fgf8 in Shionogi carcinoma 115 cells correlates with an adjacent t(5;19) translocation

Genes Chromosomes and Cancer

Volumn 45, Issue 2, 2006, Pages 169-181

  Erdreich Epstein, Anat ^a,b   Ganguly, Amit K ^a   Shi, Xiang He ^a   Zimonjic, Drazen B ^c   Shackleford, Gregory M ^a,d  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Division of Hematology Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; FIBROBLAST GROWTH FACTOR 8; MUCIN; MUCIN 10; PROTEIN; SUBMAXILLARY GLAND ANDROGEN REGULATED PROTEIN 2; TESTOSTERONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CHROMOSOME 19; CHROMOSOME 5; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; GENE; GENE FUNCTION; GENE INDUCTION; GENE INSERTION; GENE SEQUENCE; KARYOTYPING; MOLECULAR CLONING; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; MUC10 GENE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SMR2 GENE; SOUTHERN BLOTTING;

ANDROGENS; BASE SEQUENCE; BLOTTING, SOUTHERN; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 19; CHROMOSOMES, HUMAN, PAIR 5; DNA, NEOPLASM; FIBROBLAST GROWTH FACTOR 8; HUMANS; KARYOTYPING; MALE; MAMMARY TUMOR VIRUS, MOUSE; MOLECULAR SEQUENCE DATA; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANSLOCATION, GENETIC;

ANIMALIA; MOUSE MAMMARY TUMOR VIRUS;

EID: 31944452664     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20280     Document Type: Article

References (65)

1. Auffray C, Rougeon F. 1980. Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem 107:303-314.
2. Baratta M, Grolli S, Poletti A, Ramoni R, Motta M, Tamanini C. 2000. Role of androgens in proliferation and differentiation of mouse mammary epithelial cell line HC11. J Endocrinol 167:53-60.
3. Bartholomew C, Morishita K, Askew D, Buchberg A, Jenkins NA, Copeland NG, Ihle JN. 1989. Retroviral insertions in the CB-1/Fim-3 common site of integration activate expression of the Evi-1 gene. Oncogene 4:529-534.
4. Blackwood EM, Kadonaga JT. 1998. Going the distance: a current view of enhancer action. Science 281:61-63.
5. Bondarenko VA, Liu YV, Jiang YI, Studitsky VM. 2003. Communication over a large distance: enhancers and insulators. Biochem Cell Biol 81:241-251.
6. Bruchovsky N, Sutherland D, Meakin J, Minesita T. 1975. Androgen receptors: relationship to growth response and to intracellular androgen transport in nine variant lines of the Shionogi mouse mammary carcinoma. Biochim Biophys Acta 381:61-71.
7. Cato AC, Henderson D, Ponta H. 1987. The hormone response element of the mouse mammary tumour virus DNA mediates the progestin and androgen induction of transcription in the proviral long terminal repeat region. EMBO J 6:363-368.
8. Darbre P, Page M, King RJ. 1986. Androgen regulation by the long terminal repeat of mouse mammary tumor virus. Mol Cell Biol 6:2847-2854.
9. Emerman JT, Kalousek DK. 1987. Flow cytometric and karyotypic analyses of androgen-responsive and androgen-independent Shionogi mouse mammary tumours. Cell Biol Int Rep 11: 881-886.
10. Evangelou A, Letarte M, Marks A, Brown TJ. 2002. Androgen modulation of adhesion and antiadhesion molecules in PC-3 prostate cancer cells expressing androgen receptor. Endocrinology 143: 3897-3904.
11. Fukuchi-Shimogori T, Grove EA. 2001. Neocortex patterning by The secreted signaling molecule FGF8. Science 294:1071-1074.
12. Gelmann EP. 2003. Searching for the gatekeeper oncogene of prostate cancer. Crit Rev Oncol Hematol 46 Suppl:S11-S20.
13. Gendler SJ, Spicer AP. 1995. Epithelial mucin genes. Annu Rev Physiol 57:607-634.
14. Ghosh AK, Shankar DB, Shackleford GM, Wu K, T'Ang A, Miller GJ, Zheng J, Roy-Burman P. 1996. Molecular cloning and characterization of human FGF8 alternative messenger RNA forms. Cell Growth Differ 7:1425-1434.
15. Gnanapragasam VJ, Robson CN, Neal DE, Leung HY. 2002. Regulation of FGF8 expression by the androgen receptor in human prostate cancer. Oncogene 21:5069-5080.
16. Haga S, Imai S, Morimoto J, Okumoto M, Iwai M, Iwai Y, Hiroishi S, Mori N, Nagano K, Nishino T and others. 1994. Mouse mammary tumor virus proviral integration in the DD/Tbr mice. Breast Cancer 1:11-16.
17. Heston WE, Vlahakis G, Tsubura Y. 1964. Strain Dd, a new high mammary tumor strain, and comparison of Dd with strain C3h. J Natl Cancer Inst 32:237-251.
18. Jain RK, Safabakhsh N, Sckell A, Chen Y, Jiang P, Benjamin L, Yuan F, Keshet E. 1998. Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor. Proc Natl Acad Sci USA 95:10820-10825.
19. Jemal A, Thomas A, Murray T, Thun M. 2002. Cancer statistics, 2002. CA Cancer J Clin 52:23-47.
20. Kapoun AM, Shackleford GM. 1997. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice. Oncogene 14:2985-2989.
21. King RJB, Cambray GJ, Jagus-Smith R, Robinson JH, Smith JA. 1976. Steroid hormones and the control of tumor growth: studies on androgen responsive tumor cells in culture. In: Pasqualini JR, editor. Receptors and mechanism of action of steroid hormones, Part I. New York: Marcel Dekker. p 215-260.
22. Kouhara H, Koga M, Kasayama S, Tanaka A, Kishimoto T, Sato B. 1994. Transforming activity of a newly cloned androgen-induced growth factor. Oncogene 9:455-462.
23. Kuriki K, Kamiakito T, Yoshida H, Saito K, Fukayama M, Tanaka A. 2000. Integration of proviral sequences, but not at the common integration sites of the FGF8 locus, in an androgen-dependent mouse mammary Shionogi carcinoma. Cell Mol Biol (Noisyle-grand) 46:1147-1156.
24. Lazo PA, Lee JS, Tsichlis PN. 1990. Long-distance activation of the Myc protooncogene by provirus insertion in Mlvi-1 or Mlvi-4 in rat T-cell lymphomas. Proc Natl Acad Sci USA 87:170-173.
25. Leung HY, Dickson C, Robson CN, Neal DE. 1996. Over-expression of fibroblast growth factor-8 in human prostate cancer. Oncogene 12:1833-1835.
26. Lewandoski M, Sun X, Martin GR. 2000. Fgf8 signalling from the AER is essential for normal limb development. Nat Genet 26: 460-463.
27. Lorenzi MV, Long JE, Miki T, Aaronson SA. 1995. Expression cloning, developmental expression and chromosomal localization of fibroblast growth factor-8. Oncogene 10:2051-2055.
28. MacArthur CA, Lawshe A, Shankar DB, Heikinheimo M, Shackleford GM. 1995a. FGF-8 isoforms differ in NIH3T3 cell transforming potential. Cell Growth Differ 6:817-825.
29. MacArthur CA, Shankar DB, Shackleford GM. 1995b. Fgf-8, activated by proviral insertion, cooperates with the Wnt-1 transgene in murine mammary tumorigenesis. J Virol 69:2501-2507.
30. Mattila MM, Ruohola JK. Valve EM, Tasanen MJ, Seppanen JA, Harkonen PL. 2001. FGF-8b increases angiogenic capacity and tumor growth of androgen-regulated S115 breast cancer cells. Oncogene 20:2791-2804.
31. Meyers EN, Martin GR. 1999. Differences in left-right axis pathways in mouse and chick: functions of FGF8 and SHH. Science 285:403-406.
32. Mills JS, Needham M, Parker MG. 1987. A secretory protease inhibitor requires androgens for its expression in male sex accessory tissues but is expressed constitutively in pancreas. Embo J 6:3711-3717.
33. Minesita T, Yamaguchi K. 1965. An androgen-dependent mouse mammary tumor. Cancer Res 25:1168-1175.
34. Mitchell S, Abel P, Madaan S, Jeffs J, Chaudhary K, Stamp G, Lalaniel N. 2002. Androgen-dependent regulation of human MUC1 mucin expression. Neoplasia 4:9-18.
35. Nakamura N, Yamanishi H, Lu J, Uchida N, Nonomura N, Matsumoto K, Sato B. 1989. Growth-stimulatory effects of androgen, high concentration of glucocorticoid or fibroblast growth factors on a cloned cell line from Shionogi carcinoma 115 cells in a serum-free medium. J Steroid Biochem 33:13-18.
36. Nusse R, van Doyen A, Cox D, Fung YK, Varmus H. 1984. Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15. Nature 307:131-136.
37. Okumoto M, Nishikawa R, Iwai M, Iwai Y, Imai S, Mori N, Takamori Y, Yagasaki O. 1991. The different activation of int genes in mammary carcinomas developed in three mouse strains harboring mouse mammary tumor viruses derived from DD/Tbr. Jikken Dobutsu 40:431-438.
38. Payson RA, Wu J, Liu Y, Chiu IM. 1996. The human FGF-8 gene localizes on chromosome 10q24 and is subjected to induction by androgen in breast cancer cells. Oncogene 13:47-53.
39. Rajan L, Broussard D, Lozano M, Lee CG, Kozak CA, Dudley JP. 2000. The c-myc locus is a common integration site in type B retrovirus-induced T-cell lymphomas. J Virol 74:2466-2471.
40. Rosinski-Chupin I, Rougeon F. 1990. A new member of the glutamine-rich protein gene family is characterized by the absence of internal repeats and the androgen control of its expression in the submandibular gland of rats. J Biol Chem 265:10709-10713.
41. Rosinski-Chupin I, Tronik D, Rougeon F. 1988. High level of accumulation of a mRNA coding for a precursor-like protein in the submaxillary gland of male rats. Proc Natl Acad Sci USA 85:8553-8557.
42. Ruohola JK, Valve EM, Karkkainen MJ, Joukov V, Alitalo K, Harkonen PL. 1999. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells. Mol Cell Endocrinol 149:29-40.
43. Ruohola JK, Valve EM, Vainikka S, Alitalo K, Harkonen PL. 1995. Androgen and fibroblast growth factor (FGF) regulation of FGF receptors in S115 mouse mammary tumor cells. Endocrinology 136:2179-2188.
44. Sambrooks J, Fritsch EF, Maniatis T. 1989. Molecular cloning, a laboratory manual. Second ed. Cold Spring Harbor: Cold Spring Harbor Laboratory Press.
45. Saric T. Shain SA. 1998. Androgen regulation of prostate cancer cell FGF-1, FGF-2, and FGF-8: preferential down-regulation of FGF-2 transcripts. Growth Factors 16:69-87.
46. Schmitt JF, Hearn MT, Risbridger GP. 1996. Expression of fibroblast growth factor-8 in adult rat tissues and human prostate carcinoma cells. J Steroid Biochem Mol Biol 57:173-178.
47. Senorale-Pose M, Rougeon F. 1997. The mouse Vcs2 gene is a composite structure which evolved by gene fusion and encodes five distinct salivary mRNA species. Gene 201:75-85.
48. Shackleford GM, Varmus HE. 1988. Construction of a clonable, infectious, and tumorigenic mouse mammary tumor virus provirus and a derivative genetic vector. Proc Natl Acad Sci USA 85:9655-9659.
49. Smith JA, King RJ. 1972. Effects of steroids on growth of an androgen-dependent mouse mammary carcinoma in cell culture. Esp Cell Res 73:351-359.
50. Steinmetz M, Hochtl J, Schnell H, Gebhard W, Zachau HG. 1980. Cloning of V region fragments from mouse liver DNA and localization of repetitive DNA sequences in the vicinity of immunoglobulin gene segments. Nucleic Acids Res 8:1721-1729.
51. Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, Wiltshire T, Orth AP, Vega RG, Sapinoso LM, Moqrich A and others. 2002. Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci USA 99:4465-4470.
52. Sved P, Scott KF, McLeod D, King NJ, Singh J, Tsatralis T, Nikolov B, Boulas J, Nallan L, Gelb MH and others. 2004. Oncogenic action of secreted phospholipase A2 in prostate cancer. Cancer Res 64:6934-6940.
53. Takatsuka D, Uchida N, Yamamoto R, Tsuji M, Terada N, Matsumoto K. 1992. Enhancement by androgen of the angiogenic ability of androgen-responsive Shionogi carcinoma 115. Anticancer Res 12:2001-2004.
54. Tanaka A, Furuya A, Yamasaki M, Hanai N, Kuriki K, Kamiakito T, Kobayashi Y, Yoshida H, Koike M, Fukayama M 1998. High frequency of fibroblast growth factor (FGF) 8 expression in clinical prostate cancers and breast tissues, immunohistochemically demonstrated by a newly established neutralizing monoclonal antibody against FGF 8. Cancer Res 58:2053-2056.
55. Tanaka A, Miyamoto K, Matsuo H, Matsumoto K, Yoshida H. 1995. Human androgen-induced growth factor in prostate and breast cancer cells: its molecular cloning and growth properties. FEBS Lett 363:226-230.
56. Tanaka A, Miyamoto K, Minamino N, Takeda M, Sato B, Matsuo H, Matsumoto K. 1992. Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells. Proc Nad Acad Sci USA 89:8928-8932.
57. Tanaka S, Ueo H, Mafune K, Mori M, Wands JR, Sugimachi K. 2001. A novel isoform of human fibroblast growth factor 8 is induced by androgens and associated with progression of esophageal carcinoma. Dig Dis Sci 46:1016-1021.
58. Tronik-Le Roux D, Senorale-Pose M, Rougeon F. 1994. Three novel SMR1-related cDNAs characterized in the submaxillary gland of mice show extensive evolutionary divergence in the protein coding region. Gene 142:175-182.
59. Valve EM, Nevalainen MT, Nurmi MJ, Laato MK, Martikainen PM, Harkonen PL. 2001. Increased expression of FGF-8 isoforms and FGF receptors in human premalignant prostatic intraepithelial neoplasia lesions and prostate cancer. Lab Invest 81:815-826.
60. Valve EM, Tasanen MJ, Ruohola JK, Harkonen PL. 1998. Activation of Fgf8 in S115 mouse mammary tumor cells is associated with genomic integration of mouse mammary tumor virus. Biochem Biophys Res Commun 250:805-808.
61. Wang Z, Tufts R, Haleem R, Cai X. 1997. Genes regulated by androgen in the rat ventral prostate. Proc Nad Acad Sci USA 94: 12999-13004.
62. Winoto A, Baltimore D. 1989. A novel, inducible and T cell-specific enhancer located at the 3′ end of the T cell receptor alpha locus. EMBO J 8:729-733.
63. Yamanishi H, Tanaka A, Miyamoto K, Takeda M, Nishizawa Y, Koga M, Miyata M, Matsumoto K. 1995. An essential role of androgen-induced growth factor in glucocorticoid-dependent autocrine loop in Shionogi carcinoma 115 cells. J Steroid Biochem Mol Biol 52:49-53.
64. Zimonjic DB, Pollock JL, Westervelt P, Popescu NC, Lev TJ. 2000. Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice. Proc Nad Acad Sci USA 97:13306-13311.
65. Zimonjic DB, Popescu NC. 1994. An improved procedure for chromosome preparations from solid tumors. Cancer Genet Cytogenet 72:161.